1. Home
  2. QNCX vs GGZ Comparison

QNCX vs GGZ Comparison

Compare QNCX & GGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$3.80

Market Cap

139.2M

Sector

Health Care

ML Signal

HOLD

Logo Gabelli Global Small and Mid Cap Value Trust (The) of Beneficial Interest

GGZ

Gabelli Global Small and Mid Cap Value Trust (The) of Beneficial Interest

HOLD

Current Price

$14.32

Market Cap

112.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
QNCX
GGZ
Founded
2012
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
139.2M
112.4M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
QNCX
GGZ
Price
$3.80
$14.32
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.75
N/A
AVG Volume (30 Days)
1.1M
12.8K
Earning Date
11-12-2025
01-01-0001
Dividend Yield
N/A
5.39%
EPS Growth
N/A
N/A
EPS
N/A
1.75
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$6.79
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$9.43
52 Week High
$4.55
$12.50

Technical Indicators

Market Signals
Indicator
QNCX
GGZ
Relative Strength Index (RSI) 64.26 54.33
Support Level $3.74 $14.25
Resistance Level $4.55 $14.67
Average True Range (ATR) 0.46 0.15
MACD 0.05 0.03
Stochastic Oscillator 64.39 57.23

Price Performance

Historical Comparison
QNCX
GGZ

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About GGZ Gabelli Global Small and Mid Cap Value Trust (The) of Beneficial Interest

The Gabelli Global Small and Mid Cap Value Trust is a diversified closed-ended management investment company whose investment objective is long-term capital growth. It invests in equity securities such as common stock and preferred stock of companies.

Share on Social Networks: